Key Account Partner Amyloidosis

About this role

Requirements

• for baseline scientific and business literacy.
• Proficiency in English to conduct
• conduct complex scientific and commercial discussions, draft proposals, and present to senior stakeholders.
• Learning
• agility:
• rapidly assimilates evolving amyloidosis science, diagnostics, pathways, and access dynamics; quickly applies new insights in account plans.
• Business acumen: understands HCO economics, budgets, formulary dynamics, and access levers; builds value cases linked to account priorities and AZ
• objectives
• .
• Commercial innovation & account planning: designs tailored account plans for MDT/DMU; pilots novel engagement models (e.g., diagnostic pathways, earlier diagnosis initiatives) with measurable outcomes.
• Customer solution oriented: co-creates solutions with stakeholders that
• optimize
• the patient journey (diagnosis, referral, testing, treatment); focuses on patient-centric impact.
• Decision making and problem
• solving:
• analyzes
• barriers (clinical, operational, access), prioritizes options, and executes pragmatic, compliant solutions.
• Self-confidence: leads complex discussions with senior clinicians and administrators; navigates objections with fair-balance, evidence-led messaging.
• Omnichannel
• proficiency
• : plans and executes personalized, compliant engagement across in-person, virtual, email, webinars, and scientific materials; measures and
• optimizes
• reach and impact.
• Secondary care sales and
• account management: demonstrable success in hospital/secondary care environments
• ; understands pathways, protocols, and formulary processes.
• Stakeholder engagement in complex clinical settings: sustained relationships with mid/senior HCPs, KOLs, pharmacy, commissioning, and hospital administration; credible scientific dialogue.
• Key account management across MDT/DMU: experience engaging MDT (cardiology,
• haematology
• , neurology, internal medicine), Pharmacy, CFT, Clinical Director, hospital admin; navigates governance and decision cycles.
• Scientific and HEOR
• communication:
• translates clinical evidence, safety/efficacy, and health economic outcomes into clear value propositions; uses fair balance consistently.
• Influence in multi-stakeholder
• ecosystems:
• orchestrates decisions in accounts with multiple influencers; proves value creation (e.g., pathway improvements, diagnostic adoption, access wins) in complex DMUs.
• Cross-functional
• collaboration:
• works effectively with Market Access, Marketing, Medical/MSLs, Diagnostics, Legal/Compliance; aligns internal resources to account needs and delivers joint outcomes.
• Desirable Skills:
• Experience in Rare Diseases:
• Previous
• experience with products for
• rare diseases
• is highly desirable.
• Amyloidosis Sales Specialization:
• Specific preference for experience with
• Amyloidosis
• brands or pathways (familiarity with red-flag symptoms, diagnostic algorithms such as PYP scintigraphy, cardiac MRI, genetic testing, and referral networks).
• Degree in a science discipline:
• Enhances depth of clinical and diagnostic discussions.
• Why AstraZeneca?
• Here,
• you will join a team that blends scientific rigor with commercial excellence to change care standards.
• We work with a patient-first mindset,
• connecting the healthcare ecosystem to move faster where it counts.
• Expect real ownership,
• coaching,
• and continuous learning,
• with the freedom to test,
• learn,
• and make bold moves supported by trusted colleagues.
• Diverse perspectives come together here to spark new ideas,
• and we value kindness alongside ambition.
• As our pipeline expands,
• your contribution will help shape the future of patient care.
• So, what’s next?
• Are you already imagining yourself joining our team?
• We can’t wait to hear from you.
• Step into this pivotal role to accelerate earlier diagnosis and better outcomes in amyloidosis while shaping market strategy and partnerships that matter.
• Where can you find more?
• Our social media, Follow AstraZeneca on
• LinkedIn
• Follow AstraZeneca on
• Facebook
• Follow AstraZeneca on
• Instagram
• Date Posted
• 22-Jan-2026
• Closing Date
• 11-Feb-2026
• AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.